| Financial Year |
March 31 2023 |
| Monetary Funds |
281,362,691.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
110,705,745.59 |
| Accounts Receivable |
250,897,774.14 |
| Advances to Suppliers |
140,577,461.81 |
| Other Receivables |
215,231,519.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
217,125,446.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
96,197,495.02 |
| Total Current Assets |
1,381,299,591.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,922,650.45 |
| Long-term Equity Investment |
91,163,174.48 |
| Investment Properties |
60,428,489.43 |
| Fixed Assetes |
624,126,904.36 |
| Under-construction Projects |
456,234,761.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,257,247,013.56 |
| R&D expenses |
9,023,619.48 |
| Goodwill |
590,865,089.50 |
| Long-Term Deferred and Prepaid Expenses |
64,870,440.81 |
| Deferred Income Tax Assets |
44,894,518.95 |
| Other Non-Current Assets |
162,849,617.70 |
| Sub-Total of Non-Current Assets |
4,395,522,912.37 |
| Total Assets |
5,776,822,504.25 |
| Short-Term Loans |
507,041,636.36 |
| Trading Financial liabilities |
255,700,559.90 |
| Notes Payable |
2,446,600.00 |
| Accounts Payable |
499,619,200.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,107,802.56 |
| Taxes Payable |
45,158,241.91 |
| Interest Payable |
-- |
| Dividend Payable |
1,201,116.32 |
| Other payables |
801,154,825.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
257,738,901.51 |
| Other Current Liabilities |
4,407,085.56 |
| Sub-Total of Current Liabilities |
2,416,005,969.36 |
| Long-term Loans |
719,673,866.03 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
930,894,475.18 |
| Special Payable |
-- |
| Estimatied Liabilities |
31,879,793.81 |
| Deferred Income Tax Liabilities |
92,765,246.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,839,563,652.98 |
| Total Liabilities |
4,255,569,622.34 |
| Paid-In Capital(Or Share Stock) |
350,304,105.00 |
| Capital Surplus |
1,219,000,246.43 |
| Surplus Reserve |
45,510,007.05 |
| LESS:Treasury Stock |
130,089,641.00 |
| Undistributed Profits |
-6,869,422.86 |
| Minority Stockholder's Interest |
43,304,985.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,477,947,896.34 |
| Owner's Equity（Stockholder's Equity） |
1,521,252,881.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,776,822,504.25 |
